People · Operator
Named in public records as an officer, director or promoter · active 2010–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | — | Pharmaceuticals | Series A | $14.7M | $38.0M | 2010 |
Michael Berelowitz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Berelowitz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Harold Jacob | 1 | 2 |
| Gerald M. Ostrov | 1 | 2 |
| Gerald Martin Ostrov | 1 | 1 |
| Nadav Kidron | 1 | 1 |
| Miriam Kidron | 1 | 1 |
| Yifat Zommer | 1 | 1 |
| Yifat Hen Zommer | 1 | 1 |
| Leonard Sank | 1 | 1 |
| Joshua Hen Hexter | 1 | 1 |
| Yifat Martin Zommer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.